Mechanisms of Angiotensin-Receptor/Neprilysin Inhibition for Heart Failure with Reduced Ejection Fraction

Frederick A Masoudi , Msph + Show 2 more

https://doi.org/10.1056/nejm-jw.na49875

Copy DOI

Publication Date: Sep 2, 2019

Abstract

In the PARADIGM-HF trial, involving patients with heart failure (HF) and reduced left-ventricular (LV) ejection fraction (HFrEF),

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author